Tracking the LYEL option chain helps you see every strike and expiry on Lyell Immunopharma Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Lyell Immunopharma Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of LYEL options activity at a glance. Use our scanner to monitor the LYEL option chain in real time and filter for the LYEL options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For LYEL stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the LYEL option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where LYEL stock options are being actively traded and where they are not.
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications.
The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Lyell Immunopharma Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen LYEL options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of LYEL stock options — let the full option chain come to you, pre-filtered and ready to trade.
